HiloProbe

Improving treatment of colorectal cancer

  • CEO: Lina Olsson
  • First investment year: 2018
  • Fund: Partnerinvest North
  • Business sector: Life Science

HiloProbe has developed ColoNode®, a highly accurate and rapid test to identify a patient’s need of additional treatment after surgery for colorectal cancer.